Literature DB >> 10949823

Construction of adenovirus for high level expression of small RNAs in mammalian cells. Application to a Bcl-2 ribozyme.

P M Potter1, P P McKenzie, N Hussain, S Noonberg, C L Morton, L C Harris.   

Abstract

A series of plasmid vectors have been generated to allow the rapid construction of adenoviral vectors designed to express small RNA sequences. A truncated human U6 gene containing convenient restriction sites has been shown to be expressed at high levels following electroporation into a series of human cell lines. This gene was ligated into a promoterless adenoviral plasmid, and we have generated high titer virus by homologous recombination with adenoviral Addl327 DNA in 293 cells. Recombinant adenovirus containing a hammerhead ribozyme sequence targeted toward the Bcl-2 mRNA has been used to transduce a panel of human tumor cell lines. We have demonstrated high level expression of the recombinant U6 gene containing the ribozyme and reduction of Bcl-2 protein in transduced cells. These plasmids are suitable for the development of adenoviral vectors designed to express both ribozymes and antisense RNA in human cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10949823     DOI: 10.1385/MB:15:2:105

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  20 in total

1.  Bax is an important determinant of chemosensitivity in pediatric tumor cell lines independent of Bcl-2 expression and p53 status.

Authors:  C R McPake; D M Tillman; C A Poquette; E O George; J A Houghton; L C Harris
Journal:  Oncol Res       Date:  1998       Impact factor: 5.574

Review 2.  The proto-oncogene Bcl-2 and its role in regulating apoptosis.

Authors:  G Kroemer
Journal:  Nat Med       Date:  1997-06       Impact factor: 53.440

Review 3.  Use of recombinant adenovirus for metabolic engineering of mammalian cells.

Authors:  T C Becker; R J Noel; W S Coats; A M Gómez-Foix; T Alam; R D Gerard; C B Newgard
Journal:  Methods Cell Biol       Date:  1994       Impact factor: 1.441

4.  Adenovirus as an expression vector in muscle cells in vivo.

Authors:  B Quantin; L D Perricaudet; S Tajbakhsh; J L Mandel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

5.  Manipulation of adenovirus vectors.

Authors:  F L Graham; L Prevec
Journal:  Methods Mol Biol       Date:  1991

6.  Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice.

Authors:  T A Smith; M G Mehaffey; D B Kayda; J M Saunders; S Yei; B C Trapnell; A McClelland; M Kaleko
Journal:  Nat Genet       Date:  1993-12       Impact factor: 38.330

7.  Rhabdomyosarcoma-specific expression of the herpes simplex virus thymidine kinase gene confers sensitivity to ganciclovir.

Authors:  C L Morton; P M Potter
Journal:  J Pharmacol Exp Ther       Date:  1998-08       Impact factor: 4.030

8.  Safety evaluation of Ad5CMV-p53 in vitro and in vivo.

Authors:  W W Zhang; R Alemany; J Wang; P E Koch; N G Ordonez; J A Roth
Journal:  Hum Gene Ther       Date:  1995-02       Impact factor: 5.695

9.  Direct in vivo gene transfer and expression in malignant cells using adenovirus vectors.

Authors:  S L Brody; H A Jaffe; S K Han; R P Wersto; R G Crystal
Journal:  Hum Gene Ther       Date:  1994-04       Impact factor: 5.695

Review 10.  Expression of introduced genetic sequences in hematopoietic cells following retroviral-mediated gene transfer.

Authors:  D A Williams
Journal:  Hum Gene Ther       Date:  1990       Impact factor: 5.695

View more
  1 in total

1.  RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells.

Authors:  Jenn-Yah Yu; Stacy L DeRuiter; David L Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.